Clinical Trial Update: Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety and tolerability of EO2002 for corneal edema and related endothelial disorders; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Keratopathy
• Corneal Edema
• Corneal Endothelial Decompensation
• Corneal Endothelial Dysfunction
• Fuchs Endothelial Corneal Dystrophy
• Pseudophakic Bullous Keratopathy

Drugs mentioned

• EO2002

Snippet

Sponsor: Emmecell | Conditions: Corneal Edema, Corneal Endothelial Dysfunction | Phase 1 | Status: COMPLETED